Liquid Biopsy in Lung Cancer: Toward Non-invasive Precision Medicine
Radha Paturu, Somnath Mahapatra, Anya Chinnaiyan, Yuping Zhang et autres
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Radha Paturu, Somnath Mahapatra, Anya Chinnaiyan, Yuping Zhang et autres
Joshua Goldman, Malay Mody, Lucas Ebert, David A. Hanauer et autres
10008 Background: While most pediatric oncology patients are cured with upfront therapy, outcomes for patients with metastatic and relapsed/refractory disease remain poor. Salvage therapy is toxic and has marginal success rates, necessitating novel, personalized approaches. We established our pediatric precision oncology program …
us (code pays fourni par la source)
Yuefan Wang, Lindsey K. Olsen, Fenglong Jiao, Chenwei Wang et autres
Gastric cancer is marked by profound molecular and microenvironmental heterogeneity that limits therapeutic progress. Here, we present a 15-layer multi-omics atlas that integrates genomics, epigenomics, transcriptomics, proteomics, multiple post-translational modifications (PTMs), protein-protein interactions, metabolomics, and microbiome profiles from 159 primary gastric adenocarcinomas …
us, my, ca (code pays fourni par la source)
Jiayi Zhou, Gabriel Cruz, Somnath Mahapatra, Radha Paturu et autres
Abstract Prostate cancer exhibits diverse cellular composition, and the interaction between the tumor epithelial and tumor microenvironment (TME) cell types plays a crucial role in disease progression. However, due to technical limitations, systematic characterization of microenvironmental influences on prostate cancer progression remains …
us (code pays fourni par la source)
Zemplen Pataki, Radha Paturu, Josh Sinha, Somnath Mahapatra et autres
us (code pays fourni par la source)
Somnath Mahapatra, Radha Paturu, Fan Yang, Xuhong Cao et autres
us (code pays fourni par la source)
Jack Wadden, Tiffany Adam, Benison Lau, Rodrigo T. Cartaxo et autres
Abstract Background Stereotactic needle biopsies of brain tumors are often performed in midline or deep-seeded brain regions and are risky procedures, with additional samples for molecular diagnostics conferring additional morbidity risk. To address this issue, we investigated whether tumor DNA recovered from …
us (code pays fourni par la source)
Chandan Kumar-Sinha, Shanker Kalyana-Sundaram, Arul M. Chinnaiyan
Recurrent gene fusions in epithelial cancers. Summary of recurrent gene fusions in epithelial carcinoma across different tissues. a Gene fusions with common 5′ and 3′ genes. b Multiple 5′ partners with common 3′ genes. c Common 5′ gene partners with multiple 3′ …
Chandan Kumar-Sinha, Shanker Kalyana-Sundaram, Arul M. Chinnaiyan
Recurrent gene fusions in epithelial cancers. Summary of recurrent gene fusions in epithelial carcinoma across different tissues. a Gene fusions with common 5′ and 3′ genes. b Multiple 5′ partners with common 3′ genes. c Common 5′ gene partners with multiple 3′ …
Chandan Kumar-Sinha, Shanker Kalyana-Sundaram, Arul M. Chinnaiyan
Clinical trials involving gene fusions in epithelial cancers. (PDF 287 kb)
Chandan Kumar-Sinha, Shanker Kalyana-Sundaram, Arul M. Chinnaiyan
Clinical trials involving gene fusions in epithelial cancers. (PDF 287 kb)
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou, Terrence R. Barrette et autres
Abstract Prostate cancer is a leading cause of cancer-related death in males and is second only to lung cancer. Although effective surgical and radiation treatments exist for clinically localized prostate cancer, metastatic prostate cancer remains essentially incurable. Here we show, through gene …
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic